Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v8-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2024-09-12 | 2024-09-11 |
| Drug Identification Number | 02433087 | 02433087 |
| Brand name | MOXIFLOXACIN INJECTION | MOXIFLOXACIN INJECTION |
| Common or Proper name | MOXIFLOXACIN INJECTION | MOXIFLOXACIN INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | MOXIFLOXACIN | MOXIFLOXACIN |
| Strength(s) | 400MG | 400MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 250 mL | 250 mL |
| ATC code | J01MA | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2024-05-01 | 2024-05-01 |
| Actual start date | ||
| Estimated end date | 2024-09-16 | 2024-09-16 |
| Actual end date | 2024-09-11 | 2024-09-11 |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be extending the backorder on our Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL effective until September 16, 2024. | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be extending the backorder on our Moxifloxacin Injection 1.6 mg/mL freeflex® Bag 250 mL effective until September 16, 2024. |
| Health Canada comments |